Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2004

View Archived Issues

Apomorphine reported safe and effective in advanced Parkinson's disease

Good safety profile of testosterone and sildenafil in hypogonadal men with ED

Novel PAF antagonist protects eyes against alkali and light-induced damage

Potent neuron survival-promoting agent for treatment of acute and chronic brain injury

Extension of Lilly/Isis antisense drug discovery collaboration in cancer

The Medicines Company continues to progress in late-stage development programs

Roche continues progress during first quarter

Bisphosphonate YM-529 effective in arthritic inflammation

Antisense therapy for growth hormone disorders

Dendrimer therapy effective against excessive post-eye surgery scarring

Inhibition of cytokine release with JTE-607 attenuates acid-induced lung injury

Three series of inhibitors of CDK2 and other kinases presented by Schering-Plough

Ilex presents HMG-CoA reductase lowering agents and their use in bone disorders

Schering AG claims CDK inhibitors with utility in cancer and other disorders

New PDE7 inhibitors in early development at Pfizer

New 5-HT4 receptor agonists prepared and tested by Pfizer scientists

Roche describes new MAO-B inhibitors for AD and senile dementia therapy

Sumitomo discontinues SMP-140

Mayne launches Paxene in E.U.

Progression of Axonyx phase IIb trial of phenserine

Endo plans new trial in support of oxymorphone extended-release NDA

Symbollon acquires safety data from Mimetix

Biolex acquires Epicyte Pharmaceutical

Series E financing to advance MorphoChem compounds into clinic

NIH licenses rotavirus vaccine to BIOVIRx

Sanofi-Synthelabo files registration statement with SEC regarding Aventis

Malarone shows no impact on alertness and performance tasks

Eisai and Abbott amend Japanese agreement for KES-524

Duloxetine adds to efficacy of pelvic muscle training in urinary incontinence

Intranasal PT-141 demonstrates efficacy in erectile dysfunction

Rigiscan study shows TA-1790 acts more rapidly than sildenafil

Pharmacokinetics of DA-8159 favorable in healthy subjects

Baclofen reported to reduce drug use in cocaine-dependent subjects

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...